Patent · US Active

Method for detecting HIV-1-specific antibodies using clade C env polypeptides

US11237166B2 · kind B2 · utility

0Cited by

0References

9Claims

0Family size

Assignee

Viravaxx AG · AT

Inventors

Rudolf Valenta · Theresienfeld, AT
Daniela Gallerano · Wien, AT
Elopy N. Sibanda · Harare, ZW

Key dates

Filing date	Oct 30, 2018
Grant date	Feb 1, 2022
Priority date	—
Expiry date	Oct 30, 2038

Classification

Technology area (CPC G)Physics
CPC primaryG01N2469/20
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates to a method for detecting and/or quantifying human immunodeficiency virus (HIV) specific antibodies in a sample of a subject comprising the step of determining the presence and/or amount of antibodies binding to a) a peptide consisting of the amino acid sequence AIVCTRPNNNTRKSIRIGPGQVFYT (SEQ. ID No. 1), or b) a homolog having at least 70% identity with a peptide of a), or c) a fragment of a peptide of a) or b) consisting of 15 to 24 amino acid residues in said sample.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.